A method for measuring and modeling the physiological traits causing obstructive sleep apnea.

There is not a clinically available technique for measuring the physiological traits causing obstructive sleep apnea (OSA). Therefore, it is often difficult to determine why an individual has OSA or to what extent the various traits contribute to the development of OSA. In this study, we present a noninvasive method for measuring four important physiological traits causing OSA: 1) pharyngeal anatomy/collapsibility, 2) ventilatory control system gain (loop gain), 3) the ability of the upper airway to dilate/stiffen in response to an increase in ventilatory drive, and 4) arousal threshold. These variables are measured using a single maneuver in which continuous positive airway pressure (CPAP) is dropped from an optimum to various suboptimum pressures for 3- to 5-min intervals during sleep. Each individual's set of traits is entered into a physiological model of OSA that graphically illustrates the relative importance of each trait in that individual. Results from 14 subjects (10 with OSA) are described. Repeatability measurements from separate nights are also presented for four subjects. The measurements and model illustrate the multifactorial nature of OSA pathogenesis and how, in some individuals, small adjustments of one or another trait (which might be achievable with non-CPAP agents) could potentially treat OSA. This technique could conceivably be used clinically to define a patient's physiology and guide therapy based on the traits.

[1]  P. L. Smith,et al.  The effect of chronic nocturnal oxygen administration upon sleep apnea. , 2015, The American review of respiratory disease.

[2]  P. L. Smith,et al.  The effects of oxygen in patients with sleep apnea. , 2015, The American review of respiratory disease.

[3]  A. Malhotra,et al.  The influence of end-expiratory lung volume on measurements of pharyngeal collapsibility. , 2010, Journal of applied physiology.

[4]  M. Odeh,et al.  Interacting effects of genioglossus stimulation and mandibular advancement in sleep apnea. , 2009, Journal of applied physiology.

[5]  Yu-Lun Lo,et al.  Airway dilator muscle activity and lung volume during stable breathing in obstructive sleep apnea. , 2009, Sleep.

[6]  M. Younes,et al.  Role of respiratory control mechanisms in the pathogenesis of obstructive sleep disorders. , 2008, Journal of applied physiology.

[7]  Hartmut Schneider,et al.  Upper airway neuromuscular compensation during sleep is defective in obstructive sleep apnea. , 2008, Journal of applied physiology.

[8]  A. Jordan,et al.  Trazodone increases arousal threshold in obstructive sleep apnoea , 2008, European Respiratory Journal.

[9]  P. Hanly,et al.  Mechanisms of breathing instability in patients with obstructive sleep apnea. , 2007, Journal of applied physiology.

[10]  R. Rosenberg,et al.  A pilot study evaluating acute use of eszopiclone in patients with mild to moderate obstructive sleep apnea syndrome. , 2007, Sleep medicine.

[11]  A. Malhotra,et al.  Mechanisms used to restore ventilation after partial upper airway collapse during sleep in humans , 2007, Thorax.

[12]  A. Schwartz,et al.  Neuromechanical control of upper airway patency during sleep. , 2007, Journal of applied physiology.

[13]  S. Kurata,et al.  Effect of Mandibular Position on Upper Airway Collapsibility and Resistance , 2005, Journal of dental research.

[14]  A. Malhotra,et al.  Ventilatory control and airway anatomy in obstructive sleep apnea. , 2004, American journal of respiratory and critical care medicine.

[15]  P. Moore,et al.  Improving CPAP use by patients with the sleep apnoea/hypopnoea syndrome (SAHS). , 2003, Sleep medicine reviews.

[16]  M. Younes,et al.  Contributions of upper airway mechanics and control mechanisms to severity of obstructive apnea. , 2003, American journal of respiratory and critical care medicine.

[17]  H. Engleman,et al.  Improving CPAP use by patients with the sleep apnoea/hypopnoea syndrome (SAHS). , 2003, Sleep medicine reviews.

[18]  D. Gozal,et al.  Effect of supplemental oxygen on sleep architecture and cardiorespiratory events in preterm infants. , 2002, Pediatrics.

[19]  J. Dempsey,et al.  Effect of ventilatory drive on carbon dioxide sensitivity below eupnea during sleep. , 2002, American journal of respiratory and critical care medicine.

[20]  M. Younes,et al.  Chemical control stability in patients with obstructive sleep apnea. , 2001, American journal of respiratory and critical care medicine.

[21]  Y. Inoue,et al.  Clinical efficacy and indication of acetazolamide treatment on sleep apnea syndrome , 1999, Psychiatry and clinical neurosciences.

[22]  H. Folgering,et al.  Effect of low-dose acetazolamide on the ventilatory CO2 response during hypoxia in the anaesthetized cat. , 1998, The European respiratory journal.

[23]  M. Younes,et al.  Susceptibility to periodic breathing with assisted ventilation during sleep in normal subjects. , 1998, Journal of applied physiology.

[24]  P. L. Smith,et al.  The hypotonic upper airway in obstructive sleep apnea: role of structures and neuromuscular activity. , 1998, American journal of respiratory and critical care medicine.

[25]  David Watts.  Apnea , 1997, The Lancet.

[26]  E. Bruce,et al.  Ventilatory stability to transient CO2 disturbances in hyperoxia and normoxia in awake humans. , 1997, Journal of applied physiology.

[27]  R. Berry,et al.  Respiratory arousal from sleep: mechanisms and significance. , 1997, Sleep.

[28]  J. Remmers,et al.  Anatomy of pharynx in patients with obstructive sleep apnea and in normal subjects. , 1997, Journal of applied physiology.

[29]  M. Younes,et al.  Ventilatory stability during sleep studied with proportional assist ventilation (PAV). , 1996, Sleep.

[30]  Y. Nakazawa,et al.  Effects of acetazolamide on the sleep apnea syndrome and its therapeutic mechanism , 1995, Psychiatry and clinical neurosciences.

[31]  R. Berry,et al.  Triazolam in patients with obstructive sleep apnea. , 1995, American journal of respiratory and critical care medicine.

[32]  A I Pack,et al.  Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. , 1993, The American review of respiratory disease.

[33]  P. L. Smith,et al.  Effect of uvulopalatopharyngoplasty on upper airway collapsibility in obstructive sleep apnea. , 1992, The American review of respiratory disease.

[34]  R. Daroff,et al.  The International Classification of Sleep Disorders , 1991, Neurology.

[35]  D. White,et al.  The influence of increasing ventilatory effort on arousal from sleep. , 1990, The American review of respiratory disease.

[36]  C. Shapiro,et al.  Role of protriptyline and acetazolamide in the sleep apnea/hypopnea syndrome. , 1988, Sleep.

[37]  H. Kimura,et al.  Effects of acetazolamide in patients with the sleep apnoea syndrome. , 1988, Thorax.

[38]  J. Sharp,et al.  Effect of metabolic acidosis upon sleep apnea. , 1985, Chest.

[39]  A S Slutsky,et al.  Factors inducing periodic breathing in humans: a general model. , 1982, Journal of applied physiology: respiratory, environmental and exercise physiology.

[40]  R. Martin,et al.  Acute and long-term ventilatory effects of hyperoxia in the adult sleep apnea syndrome. , 1982, The American review of respiratory disease.

[41]  J. Weil,et al.  Sleep physiology at high altitude. , 1975, Electroencephalography and clinical neurophysiology.

[42]  W. S. Lazarus-Barlow,et al.  THE NATURAL DURATION OF CANCER , 1924, British medical journal.

[43]  P. L. Smith,et al.  A shift from central and mixed sleep apnea to obstructive sleep apnea resulting from low-flow oxygen. , 1985, The American review of respiratory disease.

[44]  The Natural Duration of Lung Cancer. , 1955, Canadian Medical Association journal.